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ABSTRACT 
Objective: The objective of this selective EBM review is to determine whether or not "In the 
treatment of patients with knee joint osteoarthritis, are Platelet Rich Plasma injections more 
effective than  Hyaluronic acid injections?" 
Study Design: Review of one randomized double-blind trial, one randomized cohort study, and 
one randomized control trial published in the English language in the year 2012. 
Data Sources: All studies were published in peer-reviewed journals found via the use of 
PubMed. 
Outcome(s) Measured: Patients were divided into two groups: those who received platelet rich 
plasma injections (PRP) and those who received hyaluronic injections (HA). Efficacy of PRP 
injections was compared to the efficacy of HA injections. Outcomes were measured at baseline 
and various monthly intervals post treatment using WOMAC scores. In addition, outcomes were 
measured by giving the 11 point pain intensity Numeric Rating scale (NRS), IKDC, and KOOS 
scores. 
Results: In two studies, results of PRP injections versus HA injections reached statistical 
significance and proved to be an effective form of treatment in patients with knee osteoarthritis 
(p < 0.01). In the third study, however, there was no statistical significance indicated in the use 
of PRP injections as compared to HA injections. More research studies are necessary to 
understand the full effect of PRP injections in the treatment of knee osteoarthritis.  
Conclusion: Overall, PRP injections alone cannot be the first line of treatment used for knee 
osteoarthritis. However, PRP injections are a safe and viable option for patients who do not 
benefit from other treatments like HA injections. They also tend to have a better effect on 
patients with lower-grade knee osteoarthritis.   
Key Words: Platelet Rich Plasma, Hyaluronic acid, Knee Osteoarthritis, Intra-Articular Injection  
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INTRODUCTION 
 Knee pain, joint aches, back pain and arthritis seem to be the staple signs of old age. It is 
also rather common among athletes, whose physical strain on the body makes it more prone to 
such wear-and-tear injuries. Osteoarthritis (OA) is a common type of condition that is associated 
with debilitating pain which leads to loss of function in mobility and decreases the patient's 
quality of life. Osteoarthritis, commonly known as wear and tear arthritis, is a condition in which 
a protective cartilage on the end of the bones wears down over time.
1
 The most common 
locations on the body for osteoarthritis include, but is not limited to, the knees, hips, hands, neck, 
and lower back.
1 
 This paper focuses specifically on osteoarthritis of the knees.  
 The mechanism involved in OA develops as a result of failed attempts of the 
chondrocytes to repair the damaged cartilage. In addition, the increased water content causes the 
softening of the cartilage leading to fissuring and/or micro-fractures. It was also recently 
discovered that OA can result from the complex interaction of multiple factors such as joint 
integrity, cellular and biochemical processes, genetic predisposition, and local inflammation 
mechanical forces.
2
 Some of the other risk factors associated with knee OA include age, obesity, 
trauma, occupational history, and genetic factors. 
 According to a study published in the American Journal of Public Health, osteoarthritis 
of the knees is one of five leading causes for disability among non-institutionalized adults.
3 
Knee 
and hip joint replacement procedures account for 35% of the total arthritis procedures conducted 
during a hospitalization.
4 
In 2006, OA was the principle diagnosis for 547,000 knee surgery 
hospitalizations in the United States.
5 
CDC data from 2005 shows that osteoarthritis affects 
13.9% of adults aged 25 years and older and 33.6% (12.4 million) of those who are more than 65 
years old in the United States.
6 
The incidence rate of symptomatic radiographic knee OA in 
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adults older than 20 years old is 240 per 100,000.
7  
Annually, the estimated cost of total knee 
replacement surgeries is $28.5 billion.
8 
The total direct and indirect cost of OA was $5700 per 
person in the fiscal year of 2000.
9 
 
The most common form of treatment for knee OA includes a combination of non-
pharmacological approaches and various pharmacologic therapies, including oral, topical, intra-
articular medications, and intra-articular injections such as hyaluronic acid (HA).
2
  The final 
treatment option for knee OA is surgery. However, patients will often choose non-
pharmacological and pharmacological treatments in order to delay the need for surgery. 
Autologous Platelet Rich Plasma (PRP) injection infuses growth factors into the patients' joint 
which prompts healing of the damaged knee joints. The use of Platelet Rich Plasma injections 
has also been shown to be effective in the treatment for reducing knee pain and improving 
function of knee joint in patients with knee OA in various non-randomized clinical studies.  This 
paper evaluates one randomized double-blind trial, one randomized cohort study and one 
randomized control trial to compare the efficiency of Platelet Rich Plasma injections over 
Hyaluronic acid injection for the purpose of reducing knee pain and improving function of the 
knee joint in patients affected by Osteoarthritis.   
OBJECTIVE 
 The objective of this selective EBM review is to determine whether or not "In the 
treatment of patients with knee joint osteoarthritis, are Platelet Rich Plasma injections more 
effective than  Hyaluronic acid injections?" 
METHODS 
 For this review, a specific selection criteria was used to select one randomized double-
blind trial, one randomized cohort study, one randomized control trial. All studies were selected 
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based on relevance and that the outcomes of the studies mattered to the patients (POEMs). All 
studies are published in English in peer-reviewed journals obtained via the use of PubMed.  
Keywords such as Platelet Rich Plasma, hyaluronic acid were used to generate these articles. 
Once the articles were generated, only randomized control trials published after 1999 were used 
for purpose of this review.  
 Although each of the trials had specific criteria, a common trend was seen in all three: 
patients exhibited chronic knee pain for at least 4 months and x-rays showed OA findings. The 
population used were individuals between the ages of 18 and 80. Any  individuals with previous 
knee operation, autoimmune disease, anticoagulation therapy were excluded. The intervention 
used in each of the studies was platelet rich plasma injection and was compared to standard 
treatment of hyaluronic acid injection. The studies measured the reduction of knee pain and joint 
function in patients with OA when given PRP injections versus HA using various scales, 
including IKDC, KOOS and WOMAC scores. Table 1 exhibits the specific demographics and 
characteristics of the included studies, showing specifically the inclusion and exclusion criteria 
used for patients, their age and the interventions used in each study.  
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Table 1: Demographics & Characteristics of included studies 
Study Type 
# of 
Patients 
Avg 
Age 
(in 
yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Cerza
10
 
(2012) 
RCT 
PRP: 60 
HA: 60 
Total: 
120 
PRP: 
66.5 
±11.3 
HA: 
66.2 ± 
10.6 
Patients with 
clinically and 
radiographically 
documented 
grades I, II, or 
III 
gonartherosis. 
History of 
previous knee 
operations, 
previous 
infiltrative 
treatment of the 
affected knee, 
documented 
rheumatoid or 
autoimmune 
abnormalities and 
cases of grade IV 
gonarthrosis. 
0 
4 autologous 
PRP intra-
articular 
injections 
(once a week 
for four weeks) 
Filardo
11 
(2012) 
Double-
blind RCT 
PRP: 54 
HA: 55 
Total: 
109 
PRP: 
55 
HA: 
58 
History of 
chronic pain or 
swelling of the 
knee for at least 
4 months; 
presenting with 
OA on X-ray  
Age ≥ 80 years; 
systemic disorders; 
anticoagulants 
therapy; use of 
NSAIDS in the 5 
days before blood 
donation; 
Hb ˂ 11 g/dl; PLT 
˂150,000/mm3. 
HA: 3 
3 autologous 
PRP intra-
articular 
injections 
(once a week 
for three 
weeks) 
Spakova
12
 
(2012) 
Randomiz
ed Cohort 
Study 
PRP: 60 
HA: 60 
Total: 
120 
PRP: 
52.8 ± 
12.43 
HA: 
53.2 ± 
14.53 
Chronic pain 
≥12 months; and 
the radiologic 
signs of knee 
OA Grade 1, 2, 
and 3 according 
to Kellgren and 
Lawrence 
classification. 
Hb ˂ 10 g/dl; PLT 
˂100,000/mm3; 
systemic disease, 
hematologic 
disease, 
anticoagulant 
therapy, 
glucocorticoid 
injection or HA 
within 3 months  
0 
3 autologous 
PRP intra-
articular 
injections 
(once a week 
for three 
weeks) 
 
OUTCOMES MEASURED 
 The main outcome measured in all these studies is the effectiveness of Platelet Rich 
Plasma injections over Hyaluronic acid injections in treating patients with knee osteoarthritis. 
The secondary outcome measured in the studies was the effectiveness of PRP injections on 
various grades of knee osteoarthritis. Each of the studies compared patients who received platelet 
rich plasma injections with patients who received hyaluronic acid injections at weekly intervals. 
In the study by Spakova et al, data was measured at baseline, 3 and 6 months post-treatment 
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using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores 
and the 11-point pain intensity Numeric Rating Scale (NRS). In the study by Filardo et al, data 
was evaluated before and at 2, 6, and 12 months after the treatment was administered by IKDC 
and KOOS scores. Finally, in the study by Cerza et al, the WOMAC score was measured before 
treatment and at 4, 12, and 24 weeks after the first injection. The specific statistical measures 
reported by the articles ranged from the use of p-values, one-way ANOVA scores to t-tests, and 
Tukey multiple comparisons test. 
RESULTS 
 This review evaluates three randomized control trials to assess the efficacy of Platelet 
Rich Plasma injections over Hyaluronic Acid injection for the purpose of reducing knee pain in 
patients affected by osteoarthritis. In the study by Spakova et al, 63 men and 57 women with an 
average age of 53 years were enrolled in a prospective cohort study. Patients were randomly 
divided into two groups: one group of 60 patients were treated using intra-articular autologous 
PRP injections while the control group of 60 patients were treated using intra-articular HA 
injections. For both groups, injections were administered three times in weekly intervals. Data 
was measured at baseline, 3, and 6 months after the last treatment dose was administered. At the 
beginning of the study, there was no statistically significant differences between both groups in 
regards to their age, sex, average WOMAC score, and the 11-point pain intensity NRS.  
 At the conclusion of the study, it was determined that there was a statistical significance 
(p <0.01). In the PRP group, there was an improvement in WOMAC score from the baseline at 
38.76 ± 16.50 points to 14.35 ± 14.18 points at the 3-month follow up and to 18.85 ± 14.09 
points at the 6-month follow up. Additionally, the NRS score improved from a baseline of 5.27 ± 
1.87 points to 2.06 ± 2.02 points at 3-month follow up and 2.69 ± 1.86 points at the 6-month 
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follow up. In the HA group, the WOMAC score from the baseline of 43.21 ± 13.70 points 
improved to 26.17 ± 17.47 points at the 3-month follow up and to 30.90 ± 16.57 points at the 6-
month follow up. Furthermore, the NRS score changed from a baseline of 6.02 ± 1.77 points to 
3.98 ± 2.27 points at 3-month follow up and stayed at 3.98 ± 2.27 points at the 6-month follow 
up. In both cases, improvements were observed at the 3- and 6-month follow up with respect to 
the baseline levels. 
 Table 2: WOMAC and NRS Scores at baseline, 3-month and 6-month follow up  
 Baseline 
3-month Follow 
Up 
6-month Follow 
Up 
 PRP HA PRP HA PRP HA 
WOMAC Scores 
38.76 ± 
16.50 
43.21 ± 
13.70 
14.35 ± 
14.18 
26.17 ± 
17.47 
18.85 ± 
14.09 
30.90 ± 
16.57 
NRS 
5.27 ± 
1.87 
6.02 ± 
1.77 
2.06 ± 
2.02 
3.98 ± 
2.27 
2.69 ± 
1.86 
3.98 ± 
2.27 
 
 In the study by Filardo et al, out of 109 patients, 55 were treated with weekly HA 
injections and 54 were treated with weekly PRP injections. They were evaluated at 12 months of 
follow up. The patients in both groups received treatment once a week, for 3 weeks. In an 
attempt to keep the study double blinded, all evaluations were conducted by clinical staff 
members who were not part of the injective procedure and all patients underwent blood 
harvesting to obtain autologous PRP even though it was only used for half of them. Patients were 
evaluated at baseline and at their 2-, 6-, and 12-month follow ups. Data was collected using 
IKDC and KOOS scores after the treatment. In this study, 3 failures occurred, all in the HA 
group. Two of the patients who withdrew showed signs of intolerance to some component of HA 
and the third patient withdrew from the study due to complaints of intense pain and then pursued 
other treatment options.  
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 At the conclusion of the study, it was determined that while both groups showed 
improvement from their baseline data, the comparison between the two groups was statistically 
not significant. In the PRP group, there was an improvement in IKDC score from the baseline at 
50.2 ± 15.7 points to 62.8 ± 17.6 points at the 2-month follow up and to 64.3 ± 16.4 points at the 
6-month follow up. In the HA group, the IKDC score from the baseline of 47.4 ± 15.7 points 
improved to 61.4 ± 16.2 points at the 2-month follow up and to 61.0 ± 18.2 points at the 6-month 
follow up. The KOOS scores showed a similarly trend. Detailed data is shown in Table 3 below.  
     Table 3: IKDC & KOOS Scores at baseline, 2-month, 6-month, and 12-month follow up 
 Baseline 
2-month Follow 
Up 
6-month Follow 
Up 
12-month 
Follow Up 
 PRP HA PRP HA PRP HA PRP HA 
IKDC Scores 
50.2 ± 
15.7 
47.4 ± 
15.7 
62.8 ± 
17.6 
61.4 ± 
16.2 
64.3 ± 
16.4 
61.0 ± 
18.2 
64.9 ± 
16.8 
61.7 ± 
19.0 
KOOS 
65.4 ± 
17.7 
63.1 ± 
17.4 
73.1 ± 
21.5 
71.1 ± 
18.6 
74.2 ± 
19.6 
73.2 ± 
18.1 
74.0 ± 
19.4 
74.0 
±19.4 
  
 This study, however, did reveal two important findings. One, when comparing the two 
groups, a significantly higher post-injective pain reaction was observed in the PRP group (p = 
0.039). This reaction was self-limiting and did not compromise the overall outcome. Also, this 
study observed that patients with low-grade articular degeneration had better results with the 
PRP injections at the 6 and 12 month follow-up even though it did not reach statistical 
significance (p = 0.08 and p = 0.07, respectively).  
 In the study by Cerza et al, 120 patients with clinically documented gonarthrosis were 
enrolled in this study. The patients were randomly divided into 2 groups of 60 patients. The PRP 
group received intra-articular injections of PRP while the HA group received intra-articular 
injections of HA. For both groups, injections were administered once a week for four weeks. The 
injections were administered by an unblinded physician. All patients were evaluated using a 
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WOMAC score at baseline, and at 4, 12, and 24 weeks after the treatment was initially 
administered.  
 At the conclusion of the study, it was determined that patients treated with the PRP 
injections showed statistically significant improvement in their WOMAC scores than compared 
to the patients in the HA group (p < 0.001). For the PRP group, the average WOMAC score at 
baseline of 76.9 ± 9.5 points improved to 49.6 ± 17.7 points at 4 weeks, 39.1 ± 17.8 points at 12 
weeks, and 36.5 ± 17.9 points at 24 weeks. For the HA group, the average WOMAC score at 
baseline was 75.4 ± 10.7 points, 55.2 ± 12.3 points at 4 weeks, 57.0 ± 11.7 points at 12 weeks, 
and increased to 65.1 ± 10.6 points at 24 weeks. Additionally, it was revealed that patients with 
grade III gonarthrosis in the HA group showed a marked worsening (p < 0.001) while the grade 
III patients in the PRP group did not show any statistically significant differences.  
 Table 4: WOMAC Scores at baseline, 4 weeks, 12 weeks, and 24 weeks follow up  
 Baseline 
4-week Follow 
Up 
12-week Follow 
Up 
24-week Follow 
Up 
 PRP HA PRP HA PRP HA PRP HA 
WOMAC Scores 
76.9 ± 
9.5 
75.4 ± 
10.7 
49.6 ± 
17.7 
55.2 ± 
12.3 
39.1 ± 
17.8 
57.0 ± 
11.7 
36.5 ± 
17.9 
65.1 ± 
10.6 
 
DISCUSSION 
 Presently, platelet rich plasma is used in maxillofacial surgery and increasingly accepted 
in the treatment of tendinopathy, acute and chronic muscular lesions, spinal fusion and other 
such orthopedic and sports medicine related injuries.
10
 This systematic review of three 
randomized control trials evaluated the efficiency of platelet rich plasma injections for patients 
with knee osteoarthritis. An advantage of using PRP injections as an effective form of treatment 
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is that it can be easily obtained with a simple centrifugation process. Since it is prepared from 
autologous blood, it eliminates concerns of allergic reactions or disease transfer in patients.  
 There were several notable limitations in the randomized control trials examined. First, 
each study used a different method to prepare the PRP injections. In the study by Spakova et all, 
a simple centrifugation process was used to minimize the cost of the injections. On the other 
hand, in the study by Filardo et al, a double-spinning high concentrate leukocyte PRP was used. 
The authors also froze the PRP injections to be used at a later time. The disadvantage of this 
process is that it could change the morphology and decrease the platelet function. This could 
potentially be a reason why this study did not reach statistical significance. Furthermore, the 
study by Cerza et al utilizes autologous conditioned plasma (ACP). Secondly, in two of the three 
studies reviewed, patient follow-up lasted approximately 6 months. A longer follow-up time 
frame could prove to be beneficial in understanding the full effects of the PRP injections on knee 
pain. Finally, the sample size for all the studies is too small. Including a greater population 
sample would allow the results to more accurately represent the effectiveness of PRP injections 
on a greater cross section of the patients who suffer from knee osteoarthritis.  
 The PRP injections proved to be more effective in patients with lower grade knee 
osteoarthritis (Grades I and II). The PRP injections also tend to have an initial increase in pain 
reaction in patients; however, this is a self-limiting issue and did not compromise the overall 
validity of any of the studies. Although more research is needed on the subject matter, the studies 
show that even if it is not more effective than HA injections, PRP injections are definitely a safe 
and viable option for treating patients with knee osteoarthritis who do not necessarily benefit 
from treatments like HA injections.  
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CONCLUSION 
 The answer to the proposed question is conflicting and inconclusive. The PRP injections 
seem to be more effective in the treatment of lower-grade osteoarthritis but more studies still 
need to be conducted to confirm this. Despite its wide application in clinical practice, there is 
little statistical findings reported of its efficiency in treating knee osteoarthritis over HA 
injections. Future studies should focus on how the different preparations of PRP injections would 
affect their effectiveness in treatment of knee osteoarthritis and in comparison to HA injections. 
For example, frozen double-spinning high concentrate leukocyte PRP was the only kind of PRP 
injection that did not reach statistical significance.
11
 In another study, autologous conditioned 
plasma injections reached statistical significance. This type of PRP was chosen due to its high 
content of growth factors and a significantly decreased quantity of white blood cells.
10
 Research 
examining different concentrations of white blood cells in PRP injections could also prove to be 
beneficial in understanding the overall picture of how effective PRP injections can be in treating 
patients with knee osteoarthritis. Due to a lack of clinical findings, PRP injections should not be 
used as the first line of treatment for patients with knee osteoarthritis. 
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